In conclusion, the present findings decipher that EGFR mutations enhance the NSCLC expression of TGF-β, which contributes to the suppression of CD8+ T cell infiltration, proliferation, and cytotoxicity in the TME. Here, CD8A is linked to non-small cell lung carcinoma.